✦ LIBER ✦

Cyclophosphamide, epirubicin, and vincristine (CEV) vs cisplatin and etoposide (PE) in the treatment of small cell lung cancer (SCLC): A randomized study

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin and etoposide versus cyclophos

✍ Veronesi, A.; Cartel, G.; CriveUari, D.; Magri, M.D.; Valentina, M.Delia; Folado 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 595 KB

Cisplatin and etoposide versus cyclophos

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 147 KB

A phase II study of cyclophosphamide / a

✍ Hara, N.; Ichinose, Y.; Kuba, M.; Ichikawa, Y.; Ninomiya, K.; Shima, K.; Yamamot 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 162 KB

40 Prospective randomized trial of high-

✍ González-Larriba, J.L.; Artal, A.; Barneto, I.; Gómez-Codina, J.; Isla, D.; Carr 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Ifosfamide, epirubicin and vincristine a

✍ Rodrígeuz, CA; Martín, G; López, Y; Cruz, JJ 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Pilot study of cyclophosphamide-doxorubi

✍ Taisuke Ohnoshi; Shunkichi Hiraki; Hiroshi Ueoka; Katsuyuki Kiura; Haruhito Kame 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB